Post by
EbbFlow88 on Aug 12, 2022 12:02pm
Knights Loans
I can't remember but I think the number of loans has decreased. Seems like they have been letting them run off and not renewing.
The Synergy loan is maturing in 2022 and 60 degree pharma and M8 in 2023. That would be about $24M in proceeds to redirect to M&A.
They already said they will not be investing in any new funds but does anyone have any ideas about loans?
Comment by
MrMugsy on Aug 13, 2022 11:19am
I think they would still entertain loans but Samira is interested in real collateral (e.g. Samira wasn't interested in the Appili deal for that reason but Loadzone Holdings was). As a one-stop-shop for young and upcoming drug developers, I think there is always room for negotiation and to offer cash as a loan or cash for ownership rights. Many factors at play in the final deal decisions
Comment by
curiousj on Aug 13, 2022 12:21pm
any news on synergy as a going concern? loan repmt doesn't seem promising